COM:BLUEPRINTMEDICINES
Blueprint Medicines
- Stock
Last Close
96.62
22/11 21:00
Market Cap
5.90B
Beta: -
Volume Today
663.53K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -20.91M - | -40.28M 92.64% | -52.77M 30.99% | -72.50M 37.38% | -148.12M 104.32% | -236.64M 59.76% | -347.69M 46.93% | 313.88M 190.28% | -644.09M 305.20% | -557.52M 13.44% | -506.98M 9.06% | |
depreciation and amortization | 501K - | 622K 24.15% | 948K 52.41% | 1.58M 66.88% | 1.58M 0.25% | 4.25M 169.07% | 5.26M 23.86% | 6.56M 24.72% | 6.48M 1.22% | 11.73M 81.12% | 11.66M 0.60% | |
deferred income tax | -4K - | 100K 2,600% | 445K 345% | 301K 32.36% | -320K 206.31% | -4.95M - | 466K 109.42% | 1.36M 192.06% | 23.20M - | |||
stock based compensation | 351K - | 2.33M 562.68% | 5.18M 122.70% | 6.14M 18.53% | 12.52M 103.96% | 30.53M 143.82% | 54.65M 78.99% | 75.53M 38.19% | 91.63M 21.32% | 98.97M 8.01% | 92.67M 6.36% | |
change in working capital | 1.01M - | 1.75M 72.95% | 14.41M 722.55% | 39.89M 176.77% | 14.44M 63.79% | 31.24M 116.33% | 9.72M 68.87% | -15.62M 260.60% | -23.68M 51.62% | -53.77M 127.07% | -41.13M 23.51% | |
accounts receivables | -3.41M - | -163K 95.23% | 3.58M 2,294.48% | -599K - | -6.39M 966.28% | -18.14M 184.06% | 1.57M 108.66% | -7.65M 586.90% | ||||
inventory | -78K - | 6.94M 8,996.15% | 6.87M 0.95% | 8.97M - | -6.71M 174.77% | -12.56M 87.28% | -8.92M 28.97% | -4.37M 51.06% | ||||
accounts payables | 541K - | -512K 194.64% | 1.39M 371.68% | 4K 99.71% | 1.53M 38,200% | -445K 129.05% | 1.45M 425.39% | -791K 154.63% | 4.22M 633.63% | -5.82M 237.79% | 1.88M 132.32% | |
other working capital | 472K - | 2.26M 379.66% | 16.51M 629.33% | 33.11M 100.50% | 2.46M 92.57% | 31.68M 1,188.53% | -94K 100.30% | -1.73M 1,743.62% | 2.80M 261.74% | -40.60M 1,548.56% | -30.99M 23.68% | |
other non cash items | 26K - | 85K 226.92% | 109K 28.24% | 73K 33.03% | 32K 56.16% | -4.39M 13,809.38% | 4.99M 213.77% | 6.22M 24.62% | 269.64M 4,235.08% | -1.70M 100.63% | -16.27M 858.93% | |
net cash provided by operating activities | -19.02M - | -35.40M 86.07% | -31.68M 10.52% | -24.51M 22.61% | -119.86M 388.99% | -175.01M 46.01% | -278.01M 58.86% | 387.04M 239.21% | -298.65M 177.16% | -502.28M 68.18% | -436.85M 13.03% | |
investments in property plant and equipment | -257K - | -700K 172.37% | -4.88M 597.57% | -2.35M 51.79% | -15.51M 558.96% | -12.68M 18.28% | -14.01M 10.54% | -3.16M 77.46% | -261.24M 8,169.74% | -8.92M 96.59% | -16.06M 80.09% | |
acquisitions net | 2.45M - | 431.09M 17,473.99% | 258.15M 40.12% | |||||||||
purchases of investments | -264.47M - | -360.83M 36.44% | -801.24M 122.05% | -738.39M 7.84% | -969.44M 31.29% | -655.45M 32.39% | -489.70M 25.29% | -766.36M 56.49% | ||||
sales maturities of investments | 48M - | 304M 533.33% | 652.83M 114.75% | 735.93M 12.73% | 538.35M 26.85% | 690.83M 28.32% | 349.37M 49.43% | 1.06B 202.39% | ||||
other investing activites | -1.20M - | 119K 109.95% | -3.50M 3,042.02% | -2.45M - | -431.09M 17,473.99% | -258.15M 40.12% | -290K 99.89% | 1 100.00% | ||||
net cash used for investing activites | -257K - | -700K 172.37% | -6.08M 768.43% | -218.70M 3,497.66% | -75.85M 65.32% | -161.09M 112.38% | -16.47M 89.78% | -434.25M 2,537.25% | -225.86M 47.99% | -149.54M 33.79% | 274.04M 283.25% | |
debt repayment | -750K - | -1.81M 140.80% | -3.33M 84.55% | -2.58M 22.50% | -1.69M 34.57% | -553.61M - | -97.93M 82.31% | |||||
common stock issued | 53K - | 268K 405.66% | 157.07M 58,509.70% | 136.05M 13.38% | 547.50M 302.41% | 6.42M 98.83% | 341.04M 5,207.98% | 582.49M 70.80% | 50.72M 91.29% | 8.20M 83.84% | 21.34M 160.32% | |
common stock repurchased | 259K - | 928K 258.30% | 5.27M 468.00% | |||||||||
dividends paid | -259K - | -928K 258.30% | -5.27M 468.00% | |||||||||
other financing activites | 17.94M - | 81.83M 356.18% | -2.05M 102.50% | -143K 93.01% | -965K 574.83% | -281K 70.88% | -400K 42.35% | 35.27M 8,916.25% | 1.11B - | 195.82M 82.31% | ||
net cash used provided by financing activities | 17.99M - | 81.35M 352.16% | 153.22M 88.34% | 132.58M 13.47% | 543.95M 310.29% | 4.45M 99.18% | 340.64M 7,547.91% | 617.76M 81.35% | 50.72M 91.79% | 561.81M 1,007.76% | 119.22M 78.78% | |
effect of forex changes on cash | 18K - | -345K 2,016.67% | -888K 157.39% | -207K 76.69% | 202K 197.58% | |||||||
net change in cash | -1.29M - | 45.25M 3,607.98% | 115.47M 155.16% | -110.64M 195.82% | 348.24M 414.75% | -331.64M 195.24% | 46.17M 113.92% | 570.20M 1,134.87% | -474.69M 183.25% | -90.22M 80.99% | -48.42M 46.32% | |
cash at beginning of period | 3.28M - | 1.99M 39.37% | 47.24M 2,277.45% | 162.71M 244.43% | 52.07M 68.00% | 405.07M 677.95% | 73.43M 81.87% | 119.60M 62.88% | 689.80M 476.74% | 215.12M 68.81% | 119.71M 44.35% | |
cash at end of period | 1.99M - | 47.24M 2,277.45% | 162.71M 244.43% | 52.07M 68.00% | 400.30M 668.80% | 73.43M 81.66% | 119.60M 62.88% | 689.80M 476.74% | 215.12M 68.81% | 124.90M 41.94% | 71.29M 42.93% | |
operating cash flow | -19.02M - | -35.40M 86.07% | -31.68M 10.52% | -24.51M 22.61% | -119.86M 388.99% | -175.01M 46.01% | -278.01M 58.86% | 387.04M 239.21% | -298.65M 177.16% | -502.28M 68.18% | -436.85M 13.03% | |
capital expenditure | -257K - | -700K 172.37% | -4.88M 597.57% | -2.35M 51.79% | -15.51M 558.96% | -12.68M 18.28% | -14.01M 10.54% | -3.16M 77.46% | -261.24M 8,169.74% | -8.92M 96.59% | -16.06M 80.09% | |
free cash flow | -19.28M - | -36.10M 87.22% | -36.56M 1.27% | -26.87M 26.51% | -135.38M 403.88% | -187.69M 38.64% | -292.03M 55.59% | 383.88M 231.45% | -559.89M 245.85% | -511.20M 8.70% | -452.91M 11.40% |
All numbers in (except ratios and percentages)